NCT01483846: Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers |
|
|
| Completed | 1b | 50 | US | AV-101, L-4-Cl-KYN, Placebo, microcrystalline cellulose | VistaGen Therapeutics, Inc., Cato Research, National Institute on Drug Abuse (NIDA) | Neuropathic Pain | 09/12 | 09/12 | | |
NCT05280054: AV-101 Alone and in Combination With Probenecid in Healthy Subjects |
|
|
| Recruiting | 1 | 24 | US | AV-101, 4-chloro-kynurenine, Probenecid | VistaGen Therapeutics, Inc., Parexel | Drug Drug Interaction | 09/22 | 11/22 | | |
